| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
51,320,000 |
| Market
Cap: |
4.91(B) |
| Last
Volume: |
212,897 |
Avg
Vol: |
491,839 |
| 52
Week Range: |
$71.24 - $97.37 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P SMALLCAP 600 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 438 |
| Guru Rank Value : 3.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Haemonetics is a global healthcare company providing a suite of medical products and solutions for customers. Co.'s technology addresses medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Co. has three principal reporting segments: Plasma, which provides automated plasma collection and donor management software systems; Blood Center, which provides a range of solutions that improve donor collection centers' ability to collect and filter blood and separate blood components; and Hospital, which has four product lines, including Hemostasis Management, Vascular Closure, Transfusion Management and Cell Salvage.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
2,305 |
2,305 |
24,823 |
92,895 |
| Total Sell Value |
$218,975 |
$218,975 |
$2,201,702 |
$7,289,062 |
| Total People Sold |
1 |
1 |
4 |
9 |
| Total Sell Transactions |
1 |
1 |
7 |
29 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Burke Willaim P |
EVP, Chief Financial Officer |
• • – |
2017-10-25 |
4 |
S |
$46.76 |
$39,325 |
D/D |
(841) |
13,393 |
|
- |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2017-10-25 |
4 |
S |
$46.76 |
$5,190 |
D/D |
(111) |
3,891 |
|
- |
|
| Ryding Neil 122-62-507 |
EVP, Global Manufacturing |
• • – |
2017-10-20 |
4 |
S |
$45.70 |
$15,812 |
D/D |
(346) |
15,676 |
|
- |
|
| Abernathy Robert E |
Director |
• • – |
2017-10-17 |
4 |
A |
$45.30 |
$131,763 |
D/D |
2,909 |
2,909 |
|
- |
|
| Meelia Richard J |
Director |
• • – |
2017-08-10 |
4 |
S |
$42.02 |
$1,012,696 |
D/D |
(24,086) |
26,911 |
|
- |
|
| Meelia Richard J |
Director |
• • – |
2017-08-10 |
4 |
OE |
$32.96 |
$804,160 |
D/D |
24,086 |
34,029 |
|
- |
|
| Scanlan Jacqueline |
SVP, Global Human ResourcesOff |
• – – |
2017-07-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,122 |
|
- |
|
| Kroll Mark W |
Director |
• • – |
2017-07-27 |
4 |
A |
$39.27 |
$170,000 |
D/D |
4,329 |
26,763 |
|
- |
|
| Burzik Catherine M |
Director |
• • – |
2017-07-27 |
4 |
A |
$39.27 |
$170,000 |
D/D |
4,329 |
8,599 |
|
- |
|
| Dockendorff Charles J |
Director |
• • – |
2017-07-27 |
4 |
A |
$39.27 |
$170,000 |
D/D |
4,329 |
17,184 |
|
- |
|
| Foote Susan Bartlett |
Director |
• • – |
2017-07-27 |
4 |
A |
$39.27 |
$170,000 |
D/D |
4,329 |
20,740 |
|
- |
|
| Gelbman Ronald G |
Director |
• • – |
2017-07-27 |
4 |
A |
$39.27 |
$170,000 |
D/D |
4,329 |
54,017 |
|
- |
|
| Granadillo Pedro P |
Director |
• • – |
2017-07-27 |
4 |
A |
$39.27 |
$170,000 |
D/D |
4,329 |
31,663 |
|
- |
|
| Meelia Richard J |
Director |
• • – |
2017-07-27 |
4 |
A |
$39.27 |
$170,000 |
D/D |
4,329 |
26,911 |
|
- |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2017-07-19 |
4 |
S |
$40.39 |
$7,957 |
D/D |
(197) |
4,002 |
|
- |
|
| Simon Christopher |
President & CEO |
• • – |
2017-06-29 |
4 |
S |
$40.39 |
$145,202 |
D/D |
(3,595) |
128,845 |
|
- |
|
| Goldstein Dan |
Chief Accounting Officer |
• • – |
2017-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,080 |
4,827 |
|
- |
|
| Simon Christopher |
President & CEO |
• • – |
2017-06-06 |
4 |
A |
$41.64 |
$1,062,486 |
D/D |
25,516 |
131,383 |
|
- |
|
| Burke Willaim P |
EVP, Chief Financial Officer |
• • – |
2017-06-06 |
4 |
A |
$41.64 |
$232,476 |
D/D |
5,583 |
15,996 |
|
- |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2017-06-06 |
4 |
A |
$41.64 |
$249,965 |
D/D |
6,003 |
10,882 |
|
- |
|
| Ryding Neil 122-62-507 |
EVP, Global Manufacturing |
• • – |
2017-06-06 |
4 |
A |
$41.64 |
$99,978 |
D/D |
2,401 |
19,676 |
|
- |
|
| Merriman Ronald |
Director |
• • – |
2017-05-22 |
4 |
S |
$40.32 |
$330,427 |
D/D |
(8,196) |
17,807 |
|
- |
|
| Merriman Ronald |
Director |
• • – |
2017-05-22 |
4 |
OE |
$36.37 |
$298,089 |
D/D |
8,196 |
26,003 |
|
- |
|
| Merriman Ronald |
Director |
• • – |
2017-05-22 |
4 |
S |
$40.31 |
$704,519 |
D/D |
(17,471) |
17,807 |
|
- |
|
| Merriman Ronald |
Director |
• • – |
2017-05-22 |
4 |
OE |
$30.50 |
$560,687 |
D/D |
17,471 |
28,160 |
|
- |
|
594 Records found
|
|
Page 16 of 24 |
|
|
0.93 (0.98%) 
